Abstract

Asymptomatic individuals, called “silent spreaders” spread SARS-CoV-2 efficiently and have complicated control of the ongoing COVID-19 pandemic. As seen in previous influenza pandemics, socioeconomic and life-trajectory factors are important in disease progression and outcome. The demographics of the asymptomatic SARS-CoV-2 carriers are unknown. We used the CON-VINCE cohort of healthy, asymptomatic, and oligosymptomatic individuals that is statistically representative of the overall population of Luxembourg for age, gender, and residency to characterise this population. Gender (male), not smoking, and exposure to early-life or adult traumatic experiences increased the risk of IgA seropositivity, and the risk associated with early-life exposure was a dose-dependent metric, while some other known comorbidities of active COVID-19 do not impact it. As prior exposure to adversity is associated with negative psychobiological reactions to external stressors, we recorded psychological wellbeing during the study period. Exposure to traumatic events or concurrent autoimmune or rheumatic disease were associated with a worse evolution of anxiety and depressive symptoms throughout the lockdown period. The unique demographic profile of the “silent spreaders” highlights the role that the early-life period plays in determining our lifelong health trajectory and provides evidence that the developmental origins of health and disease is applicable to infectious diseases.

Highlights

  • IntroductionFirst reports of an outbreak of a novel coronavirus disease (COVID-19) in Wuhan, China, appeared in December 2019

  • Licensee MDPI, Basel, Switzerland.First reports of an outbreak of a novel coronavirus disease (COVID-19) in Wuhan, China, appeared in December 2019

  • IgG seroprevalence was significantly lower with only 41 participants having a positive serology result at any one point in the 12 weeks of the study, which is partly explained by the natural sequence of immune response to a recent exposure

Read more

Summary

Introduction

First reports of an outbreak of a novel coronavirus disease (COVID-19) in Wuhan, China, appeared in December 2019. This was rapidly attributed to a betacoronavirus principally affecting the respiratory system, severe acute respiratory syndrome coronavirus. This rapidly escalated, reaching the pandemic level in March 2020 [2]. More than 151 million cases of COVID-19 have been reported, and over 3 million deaths recorded worldwide [3]. COVID-19 symptoms appear between 2 and 14 days after

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call